Skip to main content
Clinical Trials/EUCTR2016-001938-96-FI
EUCTR2016-001938-96-FIActive, not recruitingPhase 1

Treatment of Giardia lamblia infections in children: randomized open-labeled trial comparing rectal metronidazole with oral tinidazole

Helsinki University Central Hospital0 sitesStarted: October 28, 2016Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • Children aged 6 months to 10 years whose clinical symptoms could be explained by giardiasis and whose fecal samples will test positive for the presence of Giardia lamblia in Uusimaa laboratory (HUSLAB).
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 180
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • 1) age <6 mo or >10 years, 2) weight <9.5 kg, 3) the absence of symptoms, 4) co-infection with another pathogen, which may cause giardiasis-like symptoms.

Investigators

Similar Trials